Endurance Wealth Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
Endurance Wealth Management's NVAX Position: Q2 2023 in Review
Endurance Wealth Management held its Novavax (NVAX) position steady in Q2 2023 at 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #652.
Endurance Wealth Management first reported a position in NVAX in Q3 2021 and has held it in 8 quarters since. The position peaked at $2K in Q3 2021. 215 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.
- Endurance Wealth Management held 10 shares of Novavax worth $0 as of Q2 2023.
- Endurance Wealth Management left its Novavax share count unchanged in Q2 2023.
- Novavax made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #652 holding.
- Endurance Wealth Management first reported a position in Novavax in Q3 2021 and has held it in 8 quarters since.
- Endurance Wealth Management's Novavax position peaked at $2K in Q3 2021.
- 215 funds tracked by Wall St. Rank held Novavax as of Q2 2023.
Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.